Skip to main content

Table 3 Comparison of in-hospital outcomes based on the presence or absence of metabolic syndrome

From: Metabolic syndrome increases operative mortality in patients with impaired left ventricular systolic function who undergo coronary artery bypass grafting: a retrospective observational study

  Metabolic Syndrome
Variables All Patients (n = 190) Absent (n = 103) Present (n = 87) P value
 In-hospital mortality 15 (7.9%) 4 (3.9%) 11 (12.6%) 0.026
 Duration of ICU Stay>48 h 67 (35.3%) 32 (31.1%) 35 (40.2%) 0.188
 Ventilation Time>48 h 25 (13.2%) 9 (8.7%) 16 (18.4%) 0.05
 Reintubation 12 (6.3%) 4 (3.9%) 8 (9.2%) 0.134
 Intra- and postoperative use of IABP 16 (8.4%) 4 (3.9%) 12 (13.8%) 0.014
 Septicemia 7 (3.7%) 1 (1.0%) 6 (6.9%) 0.049
 Ventricular fibrillation 14 (7.4%) 4 (3.9%) 10 (11.5%) 0.045
 Acute renal failure 21 (11.1%) 6 (5.8%) 15 (17.2%) 0.012
 Stroke 4 (2.1%) 1 (1.0%) 3 (3.4%) 0.334
 LCOS 12 (6.3%) 4 (3.9%) 8 (9.2%) 0.134
 Myocardial infarction 8 (4.2%) 2 (1.9%) 6 (6.9%) 0.145
 New atrial fibrillation 15 (7.9%) 8 (7.8%) 7 (8.0%) 0.943
 Gastrointestinal hemorrhage 7 (3.7%) 2 (1.9%) 5 (5.7%) 0.25
  1. (ICU = intensive care unit, IABP = intra-aortic balloon pump, LCOS = low cardiac output syndrome)
\